1. Demple B, Herman T, Chen DS. Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: definition of a family of DNA repair enzymes. Proc Natl Acad Sci U S A. 1991. 88:11450–11454.
Article
2. Robson CN, Hickson ID. Isolation of cDNA clones encoding a human apurinic/apyrimidinic endonuclease that corrects DNA repair and mutagenesis defects in E. coli xth (exonuclease III) mutants. Nucleic Acids Res. 1991. 19:5519–5523.
3. Tell G, Quadrifoglio F, Tiribelli C, Kelley MR. The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal. 2009. 11:601–620.
Article
4. Lee HM, Yuk JM, Shin DM, Yang CS, Kim KK, Choi DK, et al. Apurinic/apyrimidinic endonuclease 1 is a key modulator of keratinocyte inflammatory responses. J Immunol. 2009. 183:6839–6848.
Article
5. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol. 2005. 25:29–38.
Article
6. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension. 2000. 36:142–146.
Article
7. Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev. 1994. 74:139–162.
Article
8. Fernandes M, Onesti G, Weder A, Dykyj R, Gould AB, Kim KE, et al. Experimental model of severe renal hypertension. J Lab Clin Med. 1976. 87:561–567.
9. Parker FB Jr, Streeten DH, Farrell B, Blackman MS, Sondheimer HM, Anderson GH Jr. Preoperative and postoperative renin levels in coarctation of the aorta. Circulation. 1982. 66:513–514.
Article
10. Jeon BH, Gupta G, Park YC, Qi B, Haile A, Khanday FA, et al. Apurinic/apyrimidinic endonuclease 1 regulates endothelial NO production and vascular tone. Circ Res. 2004. 95:902–910.
11. Sengupta S, Chattopadhyay R, Mantha AK, Mitra S, Bhakat KK. Regulation of mouse-renin gene by apurinic/apyrimidinic-endonuclease 1 (APE1/Ref-1) via recruitment of histone deacetylase 1 corepressor complex. J Hypertens. 2012. 30:917–925.
Article
12. Naganuma T, Nakayama T, Sato N, Fu Z, Soma M, Yamaguchi M, et al. Haplotype-based case-control study on human apurinic/apyrimidinic endonuclease 1/redox effector factor-1 gene and essential hypertension. Am J Hypertens. 2010. 23:186–191.
Article
13. Rojo-Ortega JM, Genest J. A method for production of experimental hypertension in rats. Can J Physiol Pharmacol. 1968. 46:883–885.
Article
14. Lee SK, Kim HS, Song YJ, Joo HK, Lee JY, Lee KH, et al. Alteration of p66shc is associated with endothelial dysfunction in the abdominal aortic coarctation of rats. FEBS Lett. 2008. 582:2561–2566.
Article
15. Yoo DG, Song YJ, Cho EJ, Lee SK, Park JB, Yu JH, et al. Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems. Lung Cancer. 2008. 60:277–284.
Article
16. Kim CS, Park JB, Kim KJ, Chang SJ, Ryoo SW, Jeon BH. Effect of Korea red ginseng on cerebral blood flow and superoxide production. Acta Pharmacol Sin. 2002. 23:1152–1156.
17. Lee SK, Chung JI, Park MS, Joo HK, Lee EJ, Cho EJ, et al. Apurinic/apyrimidinic endonuclease 1 inhibits protein kinase C-mediated p66shc phosphorylation and vasoconstriction. Cardiovasc Res. 2011. 91:502–509.
Article
18. Yayama K, Horii M, Hiyoshi H, Takano M, Okamoto H, Kagota S, et al. Up-regulation of angiotensin II type 2 receptor in rat thoracic aorta by pressure-overload. J Pharmacol Exp Ther. 2004. 308:736–743.
Article
19. Goetz RM, Holtz J. Enhanced angiotensin-converting enzyme activity and impaired endothelium-dependent vasodilation in aortae from hypertensive rats: evidence for a causal link. Clin Sci (Lond). 1999. 97:165–174.
Article
20. Bell DR. Vascular smooth muscle responses to endothelial autacoids in rats with chronic coarctation hypertension. J Hypertens. 1993. 11:65–74.
Article
21. Ishimitsu T. Antihypertensive therapy considering the prevention of vascular aging. J Korean Soc Hypertens. 2011. 17:85–94.
Article
22. Choo EH, Ihm SH, Kim OR, Jang SW, Park CS, Kim HY, et al. Imatinib mesylate attenuates cardiac fibrosis in spontaneously hypertensive rats. J Korean Soc Hypertens. 2011. 17:48–56.
Article
23. Touyz RM. Oxidative stress and vascular damage in hypertension. Curr Hypertens Rep. 2000. 2:98–105.
Article
24. Sindhu RK, Roberts CK, Ehdaie A, Zhan CD, Vaziri ND. Effects of aortic coarctation on aortic antioxidant enzymes and NADPH oxidase protein expression. Life Sci. 2005. 76:945–953.
Article
25. Vaziri ND, Ni Z. Expression of NOX-I, gp91phox, p47phox and P67phox in the aorta segments above and below coarctation. Biochim Biophys Acta. 2005. 1723:321–327.
Article
26. Ungvari Z, Csiszar A, Kaminski PM, Wolin MS, Koller A. Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system. Am J Pathol. 2004. 165:219–226.
27. Jeon BH, Irani K. APE1/Ref-1: versatility in progress. Antioxid Redox Signal. 2009. 11:571–574.
Article
28. Ramana CV, Boldogh I, Izumi T, Mitra S. Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc Natl Acad Sci U S A. 1998. 95:5061–5066.
Article
29. Grosch S, Fritz G, Kaina B. Apurinic endonuclease (Ref-1) is induced in mammalian cells by oxidative stress and involved in clastogenic adaptation. Cancer Res. 1998. 58:4410–4416.
30. Bhakat KK, Mantha AK, Mitra S. Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein. Antioxid Redox Signal. 2009. 11:621–638.
Article
31. Grosch S, Kaina B. Transcriptional activation of apurinic/apyrimidinic endonuclease (Ape, Ref-1) by oxidative stress requires CREB. Biochem Biophys Res Commun. 1999. 261:859–863.
32. Harrison L, Ascione AG, Takiguchi Y, Wilson DM 3rd, Chen DJ, Demple B. Comparison of the promoters of the mouse (APEX) and human (APE) apurinic endonuclease genes. Mutat Res. 1997. 385:159–172.
Article
33. Rose P, Bond J, Tighe S, Toth MJ, Wellman TL, Briso de Montiano EM, et al. Genes overexpressed in cerebral arteries following salt-induced hypertensive disease are regulated by angiotensin II, JunB, and CREB. Am J Physiol Heart Circ Physiol. 2008. 294:H1075–H1085.
Article